BioScience Valuation (BSV) is a consulting company working at the intersection of life sciences and finance. BSV is a trusted partner for Pharma and Biotech companies and their investors, with a 500+ mandates track record of private and public clients in Europe, the US, and worldwide.
Since 2000, the company has been at the forefront of translating scientific innovation into financial value. Our services cover the entire spectrum of commercial, R&D and financial analyses and deliver unparalleled evidence-based assessments. Based on our profound subject expertise and comprehensive database coverage, our appraisals demonstrate the route to value creation from seed stage to IPO and beyond.
Our strategic alliances enable us to reach out into the US and other markets and to communicate client equity stories within the international investor community.
BSV at a glance:
Products/Services
BSV provides a broad range of services tailored to the specific needs of each client:
Pharmaceutical companies
• Implementation of value-driven R&D portfolio management
• Optimization of R&D productivity, resource/capacity planning
• Forecast of a drug´s sales potential, determination of project value and prioritization in the portfolio context
• Competitive intelligence
• Assessment of in-licensing candidates and potential M&A transactions
Biotech/Medtech companies
• Assessment and valuation of technology platforms, developement products, and the company’s growth potential
• Indication scoping (identification and prioritization of therapeutic indications based on the company’s technology)
• Definition of USP and outline of expected value evolution to create unique equity stories • Support of business development and fundraising campaigns
• Negotiation of term sheets and agreements to maximize value
Investors
• Opportunity scouting, support of internal due diligence
• Assessment of single assets and entire R&D programs
• Optimization of program/portfolio strategy
• Support of relationship building with US investor community
Strategic alliances
• LaVoie Health Science, USA (Boston, New York)
• FCF Fox Corporate Finance GmbH, Germany (Munich)
Date of Incorporation
2000
Contact:
Joachim M. Greuel, Ph.D., MBA, Managing Director, Co-FounderKerstin M. Bode-Greuel, MD, PhD. Managing Director, Co-Founder
Plattform Life Sciences: Bitte erläutern Sie uns das Geschäftsmodell der Bioscience Valuation.
Bode-Greuel: Bioscience Valuation ist eine global engagierte Boutique-Consultingfirma. Aktuell haben wir acht fest...
One dominant hypothesis in finance is the ‘Efficient Market Hypothesis’ (EMH), which states that the stock price of a security reflects all publicly available...
Die „Plattform Life Sciences“ hat am 16. November ihre Netzwerkpartner in den Faculty Club G2B (Gateway to Biotech) im Innovations- und Gründerzentrum Biotechnologie (IZB)...
Unsere Ausgabe 3/22 „Biotechnologie 2022“ ist am Samstag, 24. September, offiziell erschienen.
Folgende Schwerpunktthemen möchten wir adressieren:
Region Leipzig: Strukturwandel durch Gesundheitswirtschaft
Forschung und Entwicklung:...
Our Spring Sale Has Started
You can see how this popup was set up in our step-by-step guide: https://wppopupmaker.com/guides/auto-opening-announcement-popups/
BioScience Valuation (BSV) is a consulting company working at the intersection of life sciences and finance. BSV is a trusted partner for Pharma and Biotech companies and their investors, with a 500+ mandates track record of private and public clients in Europe, the US, and worldwide.
